Figure 2 shows that using a T1DGRS and a mixture of just 500 cases can still provide accurate and clinically informative estimates around a disease prevalence of 40%, e.g., determining the prevalence of T1D in diabetes cases rapidly requiring insulin (clinical PPV of ≈50% for identifying T1D15). This evidence concerns the gene INS and diabetes mellitus.